世界の網膜ジストロフィー治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Retinal Dystrophy Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4827
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、網膜ジストロフィー治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子治療、対症療法）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・網膜ジストロフィー治療の市場動向
・企業の競争状況、市場シェア
・網膜ジストロフィー治療の種類別市場規模と予測2016-2027（遺伝子治療、対症療法）
・網膜ジストロフィー治療の用途別市場規模と予測2016-2027（病院、専門クリニック、その他）
・網膜ジストロフィー治療の北米市場規模2016-2027（アメリカ、カナダ）
・網膜ジストロフィー治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・網膜ジストロフィー治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・網膜ジストロフィー治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・網膜ジストロフィー治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Spark Therapeutics (Roche)、Novartis AG、GlaxoSmithKline、Applied Genetic Technologies Corporation、Oxford BioMedica、Biogen、HORAMA S.A.、MeiraGTx Limited、Novelion Therapeutics、IVERIC bio、Reflection Biotechnologies）
・結論

Market Analysis and Insights: Global Retinal Dystrophy Treatment Market
The global Retinal Dystrophy Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retinal Dystrophy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retinal Dystrophy Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retinal Dystrophy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retinal Dystrophy Treatment market.

Global Retinal Dystrophy Treatment Scope and Market Size
Retinal Dystrophy Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retinal Dystrophy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Gene Therapy Treatment
Symptomatic Treatment

Segment by Application
Hospitals
Specialty Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Spark Therapeutics (Roche)
Novartis AG
GlaxoSmithKline
Applied Genetic Technologies Corporation
Oxford BioMedica
Biogen
HORAMA S.A.
MeiraGTx Limited
Novelion Therapeutics
IVERIC bio
Reflection Biotechnologies

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Dystrophy Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gene Therapy Treatment
1.2.3 Symptomatic Treatment
1.3 Market by Application
1.3.1 Global Retinal Dystrophy Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Retinal Dystrophy Treatment Market Perspective (2016-2027)
2.2 Retinal Dystrophy Treatment Growth Trends by Regions
2.2.1 Retinal Dystrophy Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retinal Dystrophy Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Retinal Dystrophy Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Retinal Dystrophy Treatment Industry Dynamic
2.3.1 Retinal Dystrophy Treatment Market Trends
2.3.2 Retinal Dystrophy Treatment Market Drivers
2.3.3 Retinal Dystrophy Treatment Market Challenges
2.3.4 Retinal Dystrophy Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Retinal Dystrophy Treatment Players by Revenue
3.1.1 Global Top Retinal Dystrophy Treatment Players by Revenue (2016-2021)
3.1.2 Global Retinal Dystrophy Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Retinal Dystrophy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retinal Dystrophy Treatment Revenue
3.4 Global Retinal Dystrophy Treatment Market Concentration Ratio
3.4.1 Global Retinal Dystrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Dystrophy Treatment Revenue in 2020
3.5 Retinal Dystrophy Treatment Key Players Head office and Area Served
3.6 Key Players Retinal Dystrophy Treatment Product Solution and Service
3.7 Date of Enter into Retinal Dystrophy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Retinal Dystrophy Treatment Breakdown Data by Type
4.1 Global Retinal Dystrophy Treatment Historic Market Size by Type (2016-2021)
4.2 Global Retinal Dystrophy Treatment Forecasted Market Size by Type (2022-2027)

5 Retinal Dystrophy Treatment Breakdown Data by Application
5.1 Global Retinal Dystrophy Treatment Historic Market Size by Application (2016-2021)
5.2 Global Retinal Dystrophy Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Retinal Dystrophy Treatment Market Size (2016-2027)
6.2 North America Retinal Dystrophy Treatment Market Size by Type
6.2.1 North America Retinal Dystrophy Treatment Market Size by Type (2016-2021)
6.2.2 North America Retinal Dystrophy Treatment Market Size by Type (2022-2027)
6.2.3 North America Retinal Dystrophy Treatment Market Size by Type (2016-2027)
6.3 North America Retinal Dystrophy Treatment Market Size by Application
6.3.1 North America Retinal Dystrophy Treatment Market Size by Application (2016-2021)
6.3.2 North America Retinal Dystrophy Treatment Market Size by Application (2022-2027)
6.3.3 North America Retinal Dystrophy Treatment Market Size by Application (2016-2027)
6.4 North America Retinal Dystrophy Treatment Market Size by Country
6.4.1 North America Retinal Dystrophy Treatment Market Size by Country (2016-2021)
6.4.2 North America Retinal Dystrophy Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Retinal Dystrophy Treatment Market Size (2016-2027)
7.2 Europe Retinal Dystrophy Treatment Market Size by Type
7.2.1 Europe Retinal Dystrophy Treatment Market Size by Type (2016-2021)
7.2.2 Europe Retinal Dystrophy Treatment Market Size by Type (2022-2027)
7.2.3 Europe Retinal Dystrophy Treatment Market Size by Type (2016-2027)
7.3 Europe Retinal Dystrophy Treatment Market Size by Application
7.3.1 Europe Retinal Dystrophy Treatment Market Size by Application (2016-2021)
7.3.2 Europe Retinal Dystrophy Treatment Market Size by Application (2022-2027)
7.3.3 Europe Retinal Dystrophy Treatment Market Size by Application (2016-2027)
7.4 Europe Retinal Dystrophy Treatment Market Size by Country
7.4.1 Europe Retinal Dystrophy Treatment Market Size by Country (2016-2021)
7.4.2 Europe Retinal Dystrophy Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Retinal Dystrophy Treatment Market Size (2016-2027)
8.2 Asia-Pacific Retinal Dystrophy Treatment Market Size by Type
8.2.1 Asia-Pacific Retinal Dystrophy Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retinal Dystrophy Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retinal Dystrophy Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Retinal Dystrophy Treatment Market Size by Application
8.3.1 Asia-Pacific Retinal Dystrophy Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retinal Dystrophy Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retinal Dystrophy Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Retinal Dystrophy Treatment Market Size by Region
8.4.1 Asia-Pacific Retinal Dystrophy Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retinal Dystrophy Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Retinal Dystrophy Treatment Market Size (2016-2027)
9.2 Latin America Retinal Dystrophy Treatment Market Size by Type
9.2.1 Latin America Retinal Dystrophy Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Retinal Dystrophy Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Retinal Dystrophy Treatment Market Size by Type (2016-2027)
9.3 Latin America Retinal Dystrophy Treatment Market Size by Application
9.3.1 Latin America Retinal Dystrophy Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Retinal Dystrophy Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Retinal Dystrophy Treatment Market Size by Application (2016-2027)
9.4 Latin America Retinal Dystrophy Treatment Market Size by Country
9.4.1 Latin America Retinal Dystrophy Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Retinal Dystrophy Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Retinal Dystrophy Treatment Market Size (2016-2027)
10.2 Middle East & Africa Retinal Dystrophy Treatment Market Size by Type
10.2.1 Middle East & Africa Retinal Dystrophy Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retinal Dystrophy Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retinal Dystrophy Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Retinal Dystrophy Treatment Market Size by Application
10.3.1 Middle East & Africa Retinal Dystrophy Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retinal Dystrophy Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retinal Dystrophy Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Retinal Dystrophy Treatment Market Size by Country
10.4.1 Middle East & Africa Retinal Dystrophy Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retinal Dystrophy Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Spark Therapeutics (Roche)
11.1.1 Spark Therapeutics (Roche) Company Details
11.1.2 Spark Therapeutics (Roche) Business Overview
11.1.3 Spark Therapeutics (Roche) Retinal Dystrophy Treatment Introduction
11.1.4 Spark Therapeutics (Roche) Revenue in Retinal Dystrophy Treatment Business (2016-2021)
11.1.5 Spark Therapeutics (Roche) Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Retinal Dystrophy Treatment Introduction
11.2.4 Novartis AG Revenue in Retinal Dystrophy Treatment Business (2016-2021)
11.2.5 Novartis AG Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Retinal Dystrophy Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Retinal Dystrophy Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Applied Genetic Technologies Corporation
11.4.1 Applied Genetic Technologies Corporation Company Details
11.4.2 Applied Genetic Technologies Corporation Business Overview
11.4.3 Applied Genetic Technologies Corporation Retinal Dystrophy Treatment Introduction
11.4.4 Applied Genetic Technologies Corporation Revenue in Retinal Dystrophy Treatment Business (2016-2021)
11.4.5 Applied Genetic Technologies Corporation Recent Development
11.5 Oxford BioMedica
11.5.1 Oxford BioMedica Company Details
11.5.2 Oxford BioMedica Business Overview
11.5.3 Oxford BioMedica Retinal Dystrophy Treatment Introduction
11.5.4 Oxford BioMedica Revenue in Retinal Dystrophy Treatment Business (2016-2021)
11.5.5 Oxford BioMedica Recent Development
11.6 Biogen
11.6.1 Biogen Company Details
11.6.2 Biogen Business Overview
11.6.3 Biogen Retinal Dystrophy Treatment Introduction
11.6.4 Biogen Revenue in Retinal Dystrophy Treatment Business (2016-2021)
11.6.5 Biogen Recent Development
11.7 HORAMA S.A.
11.7.1 HORAMA S.A. Company Details
11.7.2 HORAMA S.A. Business Overview
11.7.3 HORAMA S.A. Retinal Dystrophy Treatment Introduction
11.7.4 HORAMA S.A. Revenue in Retinal Dystrophy Treatment Business (2016-2021)
11.7.5 HORAMA S.A. Recent Development
11.8 MeiraGTx Limited
11.8.1 MeiraGTx Limited Company Details
11.8.2 MeiraGTx Limited Business Overview
11.8.3 MeiraGTx Limited Retinal Dystrophy Treatment Introduction
11.8.4 MeiraGTx Limited Revenue in Retinal Dystrophy Treatment Business (2016-2021)
11.8.5 MeiraGTx Limited Recent Development
11.9 Novelion Therapeutics
11.9.1 Novelion Therapeutics Company Details
11.9.2 Novelion Therapeutics Business Overview
11.9.3 Novelion Therapeutics Retinal Dystrophy Treatment Introduction
11.9.4 Novelion Therapeutics Revenue in Retinal Dystrophy Treatment Business (2016-2021)
11.9.5 Novelion Therapeutics Recent Development
11.10 IVERIC bio
11.10.1 IVERIC bio Company Details
11.10.2 IVERIC bio Business Overview
11.10.3 IVERIC bio Retinal Dystrophy Treatment Introduction
11.10.4 IVERIC bio Revenue in Retinal Dystrophy Treatment Business (2016-2021)
11.10.5 IVERIC bio Recent Development
11.11 Reflection Biotechnologies
11.11.1 Reflection Biotechnologies Company Details
11.11.2 Reflection Biotechnologies Business Overview
11.11.3 Reflection Biotechnologies Retinal Dystrophy Treatment Introduction
11.11.4 Reflection Biotechnologies Revenue in Retinal Dystrophy Treatment Business (2016-2021)
11.11.5 Reflection Biotechnologies Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Retinal Dystrophy Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gene Therapy Treatment
Table 3. Key Players of Symptomatic Treatment
Table 4. Global Retinal Dystrophy Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Retinal Dystrophy Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Retinal Dystrophy Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Retinal Dystrophy Treatment Market Share by Regions (2016-2021)
Table 8. Global Retinal Dystrophy Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Retinal Dystrophy Treatment Market Share by Regions (2022-2027)
Table 10. Retinal Dystrophy Treatment Market Trends
Table 11. Retinal Dystrophy Treatment Market Drivers
Table 12. Retinal Dystrophy Treatment Market Challenges
Table 13. Retinal Dystrophy Treatment Market Restraints
Table 14. Global Retinal Dystrophy Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Retinal Dystrophy Treatment Market Share by Players (2016-2021)
Table 16. Global Top Retinal Dystrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Dystrophy Treatment as of 2020)
Table 17. Ranking of Global Top Retinal Dystrophy Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Retinal Dystrophy Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Retinal Dystrophy Treatment Product Solution and Service
Table 21. Date of Enter into Retinal Dystrophy Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Retinal Dystrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Retinal Dystrophy Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Retinal Dystrophy Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Retinal Dystrophy Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Retinal Dystrophy Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Retinal Dystrophy Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Retinal Dystrophy Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Retinal Dystrophy Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Retinal Dystrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Retinal Dystrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Retinal Dystrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Retinal Dystrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Retinal Dystrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Retinal Dystrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Retinal Dystrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Retinal Dystrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Retinal Dystrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Retinal Dystrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Retinal Dystrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Retinal Dystrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Retinal Dystrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Retinal Dystrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Retinal Dystrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Retinal Dystrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Retinal Dystrophy Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Retinal Dystrophy Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Retinal Dystrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Retinal Dystrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Retinal Dystrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Retinal Dystrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Retinal Dystrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Retinal Dystrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Retinal Dystrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Retinal Dystrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Retinal Dystrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Retinal Dystrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Retinal Dystrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Retinal Dystrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Spark Therapeutics (Roche) Company Details
Table 62. Spark Therapeutics (Roche) Business Overview
Table 63. Spark Therapeutics (Roche) Retinal Dystrophy Treatment Product
Table 64. Spark Therapeutics (Roche) Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million)
Table 65. Spark Therapeutics (Roche) Recent Development
Table 66. Novartis AG Company Details
Table 67. Novartis AG Business Overview
Table 68. Novartis AG Retinal Dystrophy Treatment Product
Table 69. Novartis AG Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million)
Table 70. Novartis AG Recent Development
Table 71. GlaxoSmithKline Company Details
Table 72. GlaxoSmithKline Business Overview
Table 73. GlaxoSmithKline Retinal Dystrophy Treatment Product
Table 74. GlaxoSmithKline Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million)
Table 75. GlaxoSmithKline Recent Development
Table 76. Applied Genetic Technologies Corporation Company Details
Table 77. Applied Genetic Technologies Corporation Business Overview
Table 78. Applied Genetic Technologies Corporation Retinal Dystrophy Treatment Product
Table 79. Applied Genetic Technologies Corporation Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million)
Table 80. Applied Genetic Technologies Corporation Recent Development
Table 81. Oxford BioMedica Company Details
Table 82. Oxford BioMedica Business Overview
Table 83. Oxford BioMedica Retinal Dystrophy Treatment Product
Table 84. Oxford BioMedica Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million)
Table 85. Oxford BioMedica Recent Development
Table 86. Biogen Company Details
Table 87. Biogen Business Overview
Table 88. Biogen Retinal Dystrophy Treatment Product
Table 89. Biogen Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million)
Table 90. Biogen Recent Development
Table 91. HORAMA S.A. Company Details
Table 92. HORAMA S.A. Business Overview
Table 93. HORAMA S.A. Retinal Dystrophy Treatment Product
Table 94. HORAMA S.A. Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million)
Table 95. HORAMA S.A. Recent Development
Table 96. MeiraGTx Limited Company Details
Table 97. MeiraGTx Limited Business Overview
Table 98. MeiraGTx Limited Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million)
Table 99. MeiraGTx Limited Recent Development
Table 100. Novelion Therapeutics Company Details
Table 101. Novelion Therapeutics Business Overview
Table 102. Novelion Therapeutics Retinal Dystrophy Treatment Product
Table 103. Novelion Therapeutics Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million)
Table 104. Novelion Therapeutics Recent Development
Table 105. IVERIC bio Company Details
Table 106. IVERIC bio Business Overview
Table 107. IVERIC bio Retinal Dystrophy Treatment Product
Table 108. IVERIC bio Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million)
Table 109. IVERIC bio Recent Development
Table 110. Reflection Biotechnologies Company Details
Table 111. Reflection Biotechnologies Business Overview
Table 112. Reflection Biotechnologies Retinal Dystrophy Treatment Product
Table 113. Reflection Biotechnologies Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million)
Table 114. Reflection Biotechnologies Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Dystrophy Treatment Market Share by Type: 2020 VS 2027
Figure 2. Gene Therapy Treatment Features
Figure 3. Symptomatic Treatment Features
Figure 4. Global Retinal Dystrophy Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Specialty Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Retinal Dystrophy Treatment Report Years Considered
Figure 9. Global Retinal Dystrophy Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Retinal Dystrophy Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Retinal Dystrophy Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Retinal Dystrophy Treatment Market Share by Regions (2022-2027)
Figure 13. Global Retinal Dystrophy Treatment Market Share by Players in 2020
Figure 14. Global Top Retinal Dystrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Dystrophy Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Retinal Dystrophy Treatment Revenue in 2020
Figure 16. Global Retinal Dystrophy Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Retinal Dystrophy Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Retinal Dystrophy Treatment Market Share by Type (2016-2027)
Figure 20. North America Retinal Dystrophy Treatment Market Share by Application (2016-2027)
Figure 21. North America Retinal Dystrophy Treatment Market Share by Country (2016-2027)
Figure 22. United States Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Retinal Dystrophy Treatment Market Share by Type (2016-2027)
Figure 26. Europe Retinal Dystrophy Treatment Market Share by Application (2016-2027)
Figure 27. Europe Retinal Dystrophy Treatment Market Share by Country (2016-2027)
Figure 28. Germany Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Retinal Dystrophy Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Retinal Dystrophy Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Retinal Dystrophy Treatment Market Share by Region (2016-2027)
Figure 38. China Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Retinal Dystrophy Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Retinal Dystrophy Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Retinal Dystrophy Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Retinal Dystrophy Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Retinal Dystrophy Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Retinal Dystrophy Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Spark Therapeutics (Roche) Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021)
Figure 58. Novartis AG Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021)
Figure 60. Applied Genetic Technologies Corporation Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021)
Figure 61. Oxford BioMedica Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021)
Figure 62. Biogen Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021)
Figure 63. HORAMA S.A. Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021)
Figure 64. MeiraGTx Limited Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021)
Figure 65. Novelion Therapeutics Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021)
Figure 66. IVERIC bio Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021)
Figure 67. Reflection Biotechnologies Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の網膜障害治療市場規模・現状・予測（2021年-2027年）

Global Retinal Disorder Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4826 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、網膜障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ジェル、カプセル＆錠剤、点眼薬、軟膏）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の網膜剥離治療市場規模・現状・予測（2021年-2027年）

Global Retinal Detachment Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4824 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、網膜剥離治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（空気圧網膜固定術、強膜バックル手術、硝子体切除術、その他）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリ...

世界のデュシェンヌ型筋ジストロフィー(DMD)治療薬市場規模・現状・予測（2021年-2027年）

Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size, Status and Forecast 2021-2027
QFJ1-5718 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、デュシェンヌ型筋ジストロフィー(DMD)治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エテプリルセン、デフラザコート、アタルレン）、用途別市場規模（病院、診療所、ホームケア）、主要地域別市場規...

世界の網膜疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Retinal Disease Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4825 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、網膜疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（黄斑変性症、糖尿病性黄斑浮腫、糖尿病性網膜症、網膜静脈閉塞症）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、ア...

世界の網膜用生物製剤市場規模・現状・予測（2021年-2027年）

Global Retinal Biologics Market Size, Status and Forecast 2021-2027
QFJ1-4821 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、網膜用生物製剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（黄斑変性症、糖尿病性網膜症、糖尿病性黄斑浮腫、ブドウ膜炎、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、...

世界の網膜用バイオシミラー市場規模・現状・予測（2021年-2027年）

Global Retinal Biosimilars Market Size, Status and Forecast 2021-2027
QFJ1-4822 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、網膜用バイオシミラーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（黄斑変性症薬、糖尿病性眼疾患薬、黄斑パッカー薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（...

世界の網膜剥離診断市場規模・現状・予測（2021年-2027年）

Global Retinal Detachment Diagnostic Market Size, Status and Forecast 2021-2027
QFJ1-4823 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、網膜剥離診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（眼底写真、検眼鏡、蛍光網膜血管造影、その他）、用途別市場規模（裂孔原性網膜剥離、滲出性網膜剥離、牽引性網膜剥離）、主要地域別市場規模（北米、...

デュシェンヌ型筋ジストロフィーのグローバル市場2021

Global Duchenne Muscular Dystrophy Sales Market Report 2021
QAF27660 2021年4月20日 136Pages
本市場調査資料では、世界のデュシェンヌ型筋ジストロフィー市場について種類別（デフラザコート、プレドニゾン、その他）、用途別（男性用、女性用）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の網膜剥離治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Retinal Detachment Treatment Market The global Retinal Detachment Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
世界の網膜障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Retinal Disorder Treatment Market The global Retinal Disorder Treatment market size is projected to reach US$ 10890 million by 2027, from US$ 7860.7 million in 2020, at a CAGR of 4.3% during 2021-2027. With industry-standard accuracy in analysis and high data int…
世界のデュシェンヌ型筋ジストロフィー(DMD)治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drugs for Duchenne Muscular Dystrophy (DMD) Market The global Drugs for Duchenne Muscular Dystrophy (DMD) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
デュシェンヌ型筋ジストロフィーのグローバル市場2021 uchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle w…
世界の網膜用生物製剤市場規模・現状・予測（2021年-2027年） Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug Administration (CFDA) for the treatment of retinal diseases. Advancements in technologies and new mechanism of action for different biologics to treat r…